Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 354 Magnetic Resonance Spectroscopy 252 Biopsy 222 Nivolumab 69 Cyclophosphamide 65 Carboplatin 56 Radiation 53 Paclitaxel 53 X-Rays 52 pembrolizumab 51 Taxes 51 Immunoglobulin G 51 Disulfides 51 Cisplatin 49 Platinum 45 1,2-diaminocyclohexaneplatinum II citrate 45 Doxorubicin 44 Radiotherapy 42 Ipilimumab 38 atezolizumab 37 fludarabine 35 Gemcitabine 35 CTLA-4 Antigen 35 olaparib 32 Vincristine 31 Prednisone 31 Bevacizumab 30 venetoclax 27 Cytarabine 27 Phantoms, Imaging 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × abrysvo × 1 year × Clear all

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡